LENZ
LENZ
US52635N1037
LENZ Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
114.53M EUR
178.45M EUR
286.89M EUR
501.52M EUR
Enterprise Value
-108.52M EUR
154.81M EUR
262.79M EUR
477.15M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-1.19x
--
--
--
Price to Sales
5.33x
8.31x
13.67x
26.27x
Price to Book
0.52x
0.81x
1.16x
1.76x
EV/Revenue
-5.05x
7.21x
12.52x
25x
EV/EBITDA
0.8x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-62.21%
-64.12%
-30.48%
-10.74%
ende